Skip to main content

26.11.2019 | Correspondence

Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendrogliomas

verfasst von: C. Feller, M. Felix, T. Weiss, C. Herold-Mende, F. Zhang, T. Kockmann, F. Sahm, R. Aebersold, A. von Deimling, D. E. Reuss

Erschienen in: Acta Neuropathologica

Einloggen, um Zugang zu erhalten

Excerpt

WHO classification for tumours of the central nervous system strongly endorses molecular tests for the precise diagnosis of diffuse gliomas. Subclassification of isocitrate dehydrogenase (IDH)-mutant gliomas into IDH-mutant astrocytomas and oligodendrogliomas requires testing for complete 1p/19q co-deletion [1] in those cases not showing loss of ATRX expression [2]. …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Louis DN et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820CrossRef Louis DN et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820CrossRef
2.
Zurück zum Zitat Reuss DE et al (2015) ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol 129(1):133–146CrossRef Reuss DE et al (2015) ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol 129(1):133–146CrossRef
3.
Zurück zum Zitat Sturm D et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425–437CrossRef Sturm D et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425–437CrossRef
4.
Zurück zum Zitat Capper D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555(7697):469–474CrossRef Capper D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555(7697):469–474CrossRef
5.
Zurück zum Zitat Bender S et al (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24(5):660–672CrossRef Bender S et al (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24(5):660–672CrossRef
6.
Zurück zum Zitat Prieto-Granada CN et al (2016) Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST. Am J Surg Pathol 40(4):479–489CrossRef Prieto-Granada CN et al (2016) Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST. Am J Surg Pathol 40(4):479–489CrossRef
7.
Zurück zum Zitat Rohrich M et al (2016) Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathol 131(6):877–887CrossRef Rohrich M et al (2016) Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathol 131(6):877–887CrossRef
8.
Zurück zum Zitat Venneti S et al (2013) Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Brain Pathol 23(5):558–564CrossRef Venneti S et al (2013) Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Brain Pathol 23(5):558–564CrossRef
9.
Zurück zum Zitat Filipski K et al (2019) Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas. Acta Neuropathol 138(2):331–334CrossRef Filipski K et al (2019) Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas. Acta Neuropathol 138(2):331–334CrossRef
10.
Zurück zum Zitat Blasi T et al (2016) Combinatorial histone acetylation patterns are generated by motif-specific reactions. Cell Syst 2(1):49–58CrossRef Blasi T et al (2016) Combinatorial histone acetylation patterns are generated by motif-specific reactions. Cell Syst 2(1):49–58CrossRef
11.
Zurück zum Zitat Feller C et al (2015) Global and specific responses of the histone acetylome to systematic perturbation. Mol Cell 57(3):559–571CrossRef Feller C et al (2015) Global and specific responses of the histone acetylome to systematic perturbation. Mol Cell 57(3):559–571CrossRef
12.
Zurück zum Zitat van Attikum H, Gasser SM (2009) Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol 19(5):207–217CrossRef van Attikum H, Gasser SM (2009) Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol 19(5):207–217CrossRef
13.
Zurück zum Zitat Zentner GE, Henikoff S (2013) Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol 20(3):259–266CrossRef Zentner GE, Henikoff S (2013) Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol 20(3):259–266CrossRef
Metadaten
Titel
Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendrogliomas
verfasst von
C. Feller
M. Felix
T. Weiss
C. Herold-Mende
F. Zhang
T. Kockmann
F. Sahm
R. Aebersold
A. von Deimling
D. E. Reuss
Publikationsdatum
26.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Acta Neuropathologica
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-019-02096-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.